APOE and Alzheimer disease: The first family based studies that identified the apolipoprotein E (APOE) ε2 and ε4 alleles with two missense mutations is the strongest risk factor across genome-wide association studies (GWAS) of AD (Jansen et al., 2019; Kunkle et al., 2019).